公司资料
Emergent BioSolutions 股价、新闻与催化剂
- 股票代码:
- EBS
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
4.82 USD (-1.43%)
收盘价
最后更新: 2026年8月20日
424M USD
市值
股价为何变动
As of Aug 20, 2026, EBS closed down 1.43% at $4.82. No new same-company headline was identified in the current news window.
公司概览
业务概览
Emergent BioSolutions is a biodefense and specialty products company focused on public-health preparedness, vaccines, and medical countermeasures. Its business is centered on government and specialty healthcare contracts.
所在地与行业分类
Headquartered in the United States and listed on NYSE, Emergent sits in specialty healthcare and biodefense.
商业模式特征
The company depends on government contracts, product supply, and the execution of its public-health franchise.
生物医药行业定位
Emergent is outside biotech proper and belongs to the biodefense and specialty-products layer.
未来催化剂
- Emergent BioSolutions’ catalysts are biodefense contract awards, manufacturing execution, and any update on its public-health products. The market will care about whether the company can keep its federal-defense and infectious-disease franchise stable.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。